Andy Chen Stock Analyst Profile - Wolfe Research Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Andy Chen

    Stock Analyst at Wolfe Research

    (5)
    # 175
    Out of 5,459 analysts
    45
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Medical - Pharmaceuticals
    30 Stocks
    Name Action PT Current % Upside Ratings Updated
    ALNY Alnylam Pharmaceutic...
    Upgrades: Peer Perform
    n/a
    		n/a n/a 3 Aug 4, 2025
    VERA Vera Therapeutics
    Downgrades: Peer Perform
    n/a
    		n/a n/a 2 Aug 4, 2025
    VRNA Verona Pharma
    Initiates Coverage On: Outperform
    170
    		105.78 60.71% 1 Jul 1, 2025
    BBIO BridgeBio Pharma
    Initiates Coverage On: Outperform
    49
    		49.59 -1.19% 1 Jun 17, 2025
    SRPT Sarepta Therapeutics
    Initiates Coverage On: Peer Perform
    n/a
    		n/a n/a 1 Jun 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    55
    		47.82 15.01% 1 Jun 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Peer Perform
    n/a
    		n/a n/a 1 Jun 3, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    61
    		55.42 10.07% 3 May 19, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    21
    		11.42 83.89% 2 Apr 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Feb 4, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Peer Perform
    n/a
    		n/a n/a 1 Feb 4, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Feb 4, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    20
    		n/a n/a 1 Feb 4, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    19
    		16.71 13.7% 1 Feb 4, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Peer Perform
    n/a
    		n/a n/a 2 Jan 3, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    697
    		707.96 -1.55% 2 Nov 12, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Oct 1, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Peer Perform
    n/a
    		n/a n/a 3 Sep 27, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    65
    		42.26 53.81% 2 Aug 26, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Jun 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Jun 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Jun 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Peer Perform
    n/a
    		n/a n/a 3 May 14, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Peer Perform
    n/a
    		n/a n/a 3 Apr 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    n/a
    		n/a n/a 1 Apr 10, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Peer Perform
    n/a
    		n/a n/a 1 Feb 15, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    17
    		11.99 41.78% 1 Feb 15, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 Feb 15, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    42
    		134.53 -68.78% 1 Feb 15, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Buy
    60
    		n/a n/a 1 Aug 8, 2023